The HbA1c test is a critical tool in the diagnosis and prognosis of diabetes. It reflects long-term glycemic control over the past 2-3 months and is a reliable biomarker for assessing chronic hyperglycemia and predicting diabetes complications. The American Diabetes Association recommends HbA1c as an alternative to fasting blood glucose for diabetes diagnosis. HbA1c is also an independent risk factor for coronary heart disease and stroke, regardless of diabetes status. It provides valuable information for diagnosing and managing diabetes, especially in low- and middle-income countries. Diabetes is a global epidemic, with rising prevalence in both developing and developed countries. In the US, over 29 million people have diabetes, with significant numbers undiagnosed. Globally, over 387 million people have diabetes, with projections of 592 million by 2035. The disease is a leading cause of death, with significant economic costs. HbA1c is not only a diagnostic tool but also a prognostic indicator. It correlates with long-term complications and cardiovascular risks. A single HbA1c test can provide insights into glycemic control and predict lipid profiles. It is recommended for regular monitoring in diabetes patients. However, the cut-point for diagnosis remains a topic of debate. HbA1c testing is convenient, non-fasting, and provides a reliable measure of average blood glucose levels. It is used in gestational diabetes diagnosis and monitoring. However, factors such as anemia, certain medications, and dietary supplements can affect HbA1c levels, leading to false results. HbA1c analysis methods include charge-based and structural-based techniques. The results must be reliable and free from interference. Standardization of HbA1c measurements is essential for accurate interpretation. HbA1c testing is accessible in many settings, including remote areas, with methods like dried blood spots on filter paper. It is an effective tool for diagnosing diabetes, especially in hard-to-reach populations. Despite its benefits, some testing strategies and cutoff ranges are still debated globally. Hemoglobin glycosylation affects RBC properties, increasing blood viscosity and impairing vascular function. HbA1c levels are associated with blood pressure changes in type 2 diabetic patients. In conclusion, HbA1c is a vital tool in diabetes diagnosis and prognosis, offering insights into long-term glycemic control and predicting complications. Its continued use as a diagnostic and prognostic tool is essential for improving patient care and clinical outcomes.The HbA1c test is a critical tool in the diagnosis and prognosis of diabetes. It reflects long-term glycemic control over the past 2-3 months and is a reliable biomarker for assessing chronic hyperglycemia and predicting diabetes complications. The American Diabetes Association recommends HbA1c as an alternative to fasting blood glucose for diabetes diagnosis. HbA1c is also an independent risk factor for coronary heart disease and stroke, regardless of diabetes status. It provides valuable information for diagnosing and managing diabetes, especially in low- and middle-income countries. Diabetes is a global epidemic, with rising prevalence in both developing and developed countries. In the US, over 29 million people have diabetes, with significant numbers undiagnosed. Globally, over 387 million people have diabetes, with projections of 592 million by 2035. The disease is a leading cause of death, with significant economic costs. HbA1c is not only a diagnostic tool but also a prognostic indicator. It correlates with long-term complications and cardiovascular risks. A single HbA1c test can provide insights into glycemic control and predict lipid profiles. It is recommended for regular monitoring in diabetes patients. However, the cut-point for diagnosis remains a topic of debate. HbA1c testing is convenient, non-fasting, and provides a reliable measure of average blood glucose levels. It is used in gestational diabetes diagnosis and monitoring. However, factors such as anemia, certain medications, and dietary supplements can affect HbA1c levels, leading to false results. HbA1c analysis methods include charge-based and structural-based techniques. The results must be reliable and free from interference. Standardization of HbA1c measurements is essential for accurate interpretation. HbA1c testing is accessible in many settings, including remote areas, with methods like dried blood spots on filter paper. It is an effective tool for diagnosing diabetes, especially in hard-to-reach populations. Despite its benefits, some testing strategies and cutoff ranges are still debated globally. Hemoglobin glycosylation affects RBC properties, increasing blood viscosity and impairing vascular function. HbA1c levels are associated with blood pressure changes in type 2 diabetic patients. In conclusion, HbA1c is a vital tool in diabetes diagnosis and prognosis, offering insights into long-term glycemic control and predicting complications. Its continued use as a diagnostic and prognostic tool is essential for improving patient care and clinical outcomes.